About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
ERIC 2022 - European Research Initiative on CLL - ERIC
http://www.ericll.org/
Videos
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
P
Combined Inhibition of Signaling and Anti-Apoptotic Pathways in CLL
By
ERIC 2022 - European Research Initiative on CLL - ERIC
FEATURING
Peter Hillmen
By
ERIC 2022 - European Research Initiative on CLL - ERIC
FEATURING
Peter Hillmen
40 views
November 8, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
Featured Video
24:08
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…
Feat.
A. Tefferi
Videos
16:41
ERIC 2022 - European Research Initiative on CLL - ERIC
My Vision of the Future of CLL
Feat.
K. Rai
15:41
ERIC 2022 - European Research Initiative on CLL - ERIC
Outcomes of Patients With CLL and COVID-19 Infection
Feat.
T. Chatzikonstantinou
17:51
ERIC 2022 - European Research Initiative on CLL - ERIC
Outcomes of SARS-CoV-2 Vaccination in Patients with CLL
Feat.
Y. Herishanu
16:25
ERIC 2022 - European Research Initiative on CLL - ERIC
Practical Considerations on COVID-19 Management in Patients With CLL
Feat.
A. Cuneo
31:28
ERIC 2022 - European Research Initiative on CLL - ERIC
The CLL Microenvironment
Feat.
T. Hartmann
30:24
ERIC 2022 - European Research Initiative on CLL - ERIC
Cellular Therapies in CLL: Present and Future
Feat.
M. Ruella
89:47
ERIC 2022 - European Research Initiative on CLL - ERIC
Round Table Discussion: Optimizing Treatment Outcomes in CLL
Feat.
C. Moreno,
B. Eichhorst,
J. Seymour,
A. Kater,
T. Kipps
35:03
ERIC 2022 - European Research Initiative on CLL - ERIC
The Molecular Basis of Resistance to Treatment in CLL
Feat.
T. Zenz
21:39
ERIC 2022 - European Research Initiative on CLL - ERIC
From Bench to Bedside: Targeting Signalling Pathways in CLL
Feat.
J. Brown
24:18
ERIC 2022 - European Research Initiative on CLL - ERIC
From Bench to Bedside: Targeting Apoptosis in CLL
Feat.
J. Seymour
21:28
ERIC 2022 - European Research Initiative on CLL - ERIC
Combined Inhibition of Signaling and Anti-Apoptotic Pathways in CLL
Feat.
P. Hillmen
40:25
ERIC 2022 - European Research Initiative on CLL - ERIC
A Multi-Omics Perspective to the Origin, Nature, and Evolution of CLL
Feat.
J. Ignacio Martín-Subero
20:55
ERIC 2022 - European Research Initiative on CLL - ERIC
The Tumor: Biomarker-Guided Treatment in CLL
Feat.
O. Al-Sawaf
19:34
ERIC 2022 - European Research Initiative on CLL - ERIC
The Host: Focus on Frailty Assessment in CLL
Feat.
L. Smolej
16:05
ERIC 2022 - European Research Initiative on CLL - ERIC
Patient Preferences: The Third Pillar in CLL Treatment Decisions
Feat.
C. Karamanidou
33:15
ERIC 2022 - European Research Initiative on CLL - ERIC
Immunological Reflections on the Origin, Nature, and Evolution of CLL
Feat.
N. Chiorazzi
17:57
ERIC 2022 - European Research Initiative on CLL - ERIC
The Nosology of CLL - An Update on CLL Diagnosis and Classification
Feat.
A. Rawstron
24:05
ERIC 2022 - European Research Initiative on CLL - ERIC
Monoclonal B-Cell Lymphocytosis: From the Lab to the Clinic
Feat.
A. Orfao
17:49
ERIC 2022 - European Research Initiative on CLL - ERIC
Early CLL Diagnosis: How Genomics Can Assist Us
Feat.
R. Brandell
